Detalhe da pesquisa
1.
Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial.
J Clin Oncol;
21(2): 298-305, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12525522